Simple rapid method for quantification of antiretrovirals by liquid chromatography—tandem mass-spectrometry

This publication has 19 references indexed in Scilit:

• Interactions among Drugs for HIV and Opportunistic Infections
  New England Journal of Medicine, 2001
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
  Annals of Internal Medicine, 2000
• Dual Protease Inhibitor Therapy in HIV-Infected Patients: Pharmacologic Rationale and Clinical Benefits
  Annual Review of Pharmacology and Toxicology, 2000
• Therapeutic Drug Monitoring of Antiretrovirals in Human Immunodeficiency Virus Infection
  Therapeutic Drug Monitoring, 2000
• Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HIV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity
  Clinical Infectious Diseases, 2000
• Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
  Clinical Pharmacokinetics, 2000
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
  The Lancet, 1999
• The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker
  AIDS, 1998
• Antiretroviral Therapy for HIV Infection
  JAMA, 1998
• Recent Advances in the Management of Human Immunodeficiency Virus Infection
  Mayo Clinic Proceedings, 1997